logo
Select company
Select metric
$ -2.81MEarning Before Interest & Taxes (EBIT)
VS
Market
37
Sector
75
Industry
88
History
90
$ -1Close
$ -1 - $ -1 52-Week Range
Ticker Information

Ticker

TTNP

Company Name

TITAN PHARMACEUTICALS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

TITAN PHARMACEUTICALS INC - Earning Before Interest & Taxes (EBIT) Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

TTNP - EBIT Historical data
DateEarning Before Interest & Taxes (EBIT)
6/30/2025$ -2.81M
3/31/2025$ -4.21M
12/31/2024$ -4.71M
9/30/2024$ -5.87M
6/30/2024$ -5.43M
3/31/2024$ -4.92M
12/31/2023$ -5.57M
9/30/2023$ -6.13M
6/30/2023$ -8.46M
3/31/2023$ -9.34M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • TITAN PHARMACEUTICALS INC's latest trailing twelve months (TTM) EBIT stands at $ -18.15M.
  • Over the past 5 years, TITAN PHARMACEUTICALS INC's average EBIT has been $ -8.82M.
  • The median EBIT for TITAN PHARMACEUTICALS INC during this period was $ -8.73M
  • TITAN PHARMACEUTICALS INC reached its highest EBIT over the past 5 years at $ -2.81M.
  • The lowest EBIT recorded by TITAN PHARMACEUTICALS INC in the same timeframe $ -18.15M

Definition of Earning Before Interest & Taxes (EBIT)

[Income Statement] Earnings before interest and taxes measures a company's net income [NetInc] prior to the deduction of interest [IntExp] and tax expenses [TaxExp].

TTNP - Earning Before Interest & Taxes (EBIT), Last 5 years

$ -18.15M

Minimum

Sep 30, 2020

$ -2.81M

Maximum

Jun 30, 2025

$ -8.82M

Average

$ -8.73M

Median

EBIT Benchmark Analysis

The chart above depicts the distribution of EBIT for companies in the Total Stock Market. The average EBIT of the companies is $ 28.81M with a standard deviation of $ 130.86M.
The following table provides additional summary stats:
EBIT in the Market:
filtered constituents3.29K
min$ -402.08M
max$ 443M
average$ 28.81M
median$ 1.05M
std$ 130.86M